Moderna's Chief Financial Officer, James M. Mock, completed a sale of 691 shares of the company's common stock on 06/03/2024. The transaction was executed at a price of $140.72 per share, resulting in a total sale value of approximately $97,237.38. Prior to this sale, Mock had acquired 1,326 shares through the exercise of derivative securities on 05/31/2024. Following these transactions, Mock's direct holdings in Moderna stock amount to 6,506 shares. The sale took place in an open market transaction, indicating a potential shift in the insider's investment strategy or liquidity needs.

Moderna's Chief Financial Officer, James M. Mock, completed a sale of 691 shares of the company's common stock on 06/03/2024. The transaction was executed at a price of $140.72 per share, resulting in a total sale value of approximately $97,237.38. Prior to this sale, Mock had acquired 1,326 shares through the exercise of derivative securities on 05/31/2024. Following these transactions, Mock's direct holdings in Moderna stock amount to 6,506 shares. The sale took place in an open market transaction, indicating a potential shift in the insider's investment strategy or liquidity needs.